667 related articles for article (PubMed ID: 30755508)
21. Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
Brand TM; Hartmann S; Bhola NE; Li H; Zeng Y; O'Keefe RA; Ranall MV; Bandyopadhyay S; Soucheray M; Krogan NJ; Kemp C; Duvvuri U; LaVallee T; Johnson DE; Ozbun MA; Bauman JE; Grandis JR
Cancer Res; 2018 May; 78(9):2383-2395. PubMed ID: 29440171
[TBL] [Abstract][Full Text] [Related]
22. Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.
Lo Cigno I; Calati F; Borgogna C; Zevini A; Albertini S; Martuscelli L; De Andrea M; Hiscott J; Landolfo S; Gariglio M
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776268
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells.
Tang X; Zhang Q; Nishitani J; Brown J; Shi S; Le AD
Clin Cancer Res; 2007 May; 13(9):2568-76. PubMed ID: 17473185
[TBL] [Abstract][Full Text] [Related]
24. Paiteling induces apoptosis of cervical cancer cells by down-regulation of the E6/E7-Pi3k/Akt pathway: A network pharmacology.
Liu Y; Zheng P; Jiao T; Zhang M; Wu Y; Zhang X; Wang S; Zhao Z
J Ethnopharmacol; 2023 Apr; 305():116062. PubMed ID: 36535331
[TBL] [Abstract][Full Text] [Related]
25. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
Harden ME; Prasad N; Griffiths A; Munger K
mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
[TBL] [Abstract][Full Text] [Related]
26. Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis.
Butz K; Geisen C; Ullmann A; Spitkovsky D; Hoppe-Seyler F
Int J Cancer; 1996 Nov; 68(4):506-13. PubMed ID: 8945623
[TBL] [Abstract][Full Text] [Related]
27. Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A.
Pim D; Massimi P; Dilworth SM; Banks L
Oncogene; 2005 Nov; 24(53):7830-8. PubMed ID: 16044149
[TBL] [Abstract][Full Text] [Related]
28. Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway.
Nair P; Somasundaram K; Krishna S
J Virol; 2003 Jun; 77(12):7106-12. PubMed ID: 12768030
[TBL] [Abstract][Full Text] [Related]
29. Expression of lymphomagenic oncogenes in T-cell lymphomas of HPV 16 transgenic mice.
Yang JT; Liu CZ; Domer P; Iannaccone P
Cancer Detect Prev; 1998; 22(5):405-15. PubMed ID: 9727621
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of mTORC2 by integrin αIIbβ3 is required for PI3Kβ-dependent activation of Akt but is dispensable for platelet spreading on fibrinogen.
Torti M; Manganaro D; Visconte C; Zarà M; Canino J; Vismara M; Canobbio I; Guidetti GF
Platelets; 2020 May; 31(4):521-529. PubMed ID: 31509054
[TBL] [Abstract][Full Text] [Related]
31. Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription.
Ordóñez RM; Espinosa AM; Sánchez-González DJ; Armendáriz-Borunda J; Berumen J
J Gen Virol; 2004 Jun; 85(Pt 6):1433-1444. PubMed ID: 15166426
[TBL] [Abstract][Full Text] [Related]
32. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
[TBL] [Abstract][Full Text] [Related]
33. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
34. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells.
Francis DA; Schmid SI; Howley PM
J Virol; 2000 Mar; 74(6):2679-86. PubMed ID: 10684283
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor-alpha promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin-dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway.
Gaiotti D; Chung J; Iglesias M; Nees M; Baker PD; Evans CH; Woodworth CD
Mol Carcinog; 2000 Feb; 27(2):97-109. PubMed ID: 10657902
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long control region.
Yasumoto S; Taniguchi A; Sohma K
J Virol; 1991 Apr; 65(4):2000-9. PubMed ID: 1848315
[TBL] [Abstract][Full Text] [Related]
37. HPV: Molecular pathways and targets.
Gupta S; Kumar P; Das BC
Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
[TBL] [Abstract][Full Text] [Related]
38. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
[TBL] [Abstract][Full Text] [Related]
39. Expression of HPV16 E6 or E7 increases integration of foreign DNA.
Kessis TD; Connolly DC; Hedrick L; Cho KR
Oncogene; 1996 Jul; 13(2):427-31. PubMed ID: 8710383
[TBL] [Abstract][Full Text] [Related]
40. Signaling pathways in HPV-associated cancers and therapeutic implications.
Chen J
Rev Med Virol; 2015 Mar; 25 Suppl 1():24-53. PubMed ID: 25752815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
